KALA BIO, Inc.
KALA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001479419
No open-market purchases or sales by KALA BIO, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $1.21M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by KALA BIO, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for KALA BIO, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Lazar David E. | Chief Executive Officer | – | Dec 22, 2025 | 2 |
| Brazzell Romulus K | SEE REMARKS | 35,952 | Oct 24, 2025 | 1 |
| Iwicki Mark T | Director | 103,540 | Oct 24, 2025 | 1 |
| Bazemore Todd | Director | 35,932 | Oct 24, 2025 | 1 |
| Reumuth Mary | CHIEF FINANCIAL OFFICER | 28,906 | Oct 24, 2025 | 1 |
| Kharabi Darius | CHIEF BUSINESS OFFICER | 41,760 | Oct 24, 2025 | 1 |
| Baker Julian | Other: Former 10% owner | 425,006Indirect | Oct 2, 2025 | 1 |
| Baker Felix | Other: Former 10% owner | 425,006Indirect | Oct 2, 2025 | 1 |
| Baker Bros. Advisors LP | Other: Former 10% owner | 425,006Indirect | Oct 2, 2025 | 1 |
| Baker Bros. Advisors (GP) LLC | Other: Former 10% owner | 425,006Indirect | Oct 2, 2025 | 1 |
| Perry Gregory D | Director | 13,344 | Jun 17, 2025 | 0 |
| Koven Andrew I | Director | 16,972 | Jun 17, 2025 | 0 |
| Rosen Howard B | Director | 16,240 | Jun 17, 2025 | 0 |
| Myers C. Daniel | Director | 10,374 | Jun 17, 2025 | 0 |
| Farid Marjan | Director | 10,242 | Jun 17, 2025 | 0 |
| Blumenkranz Mark S. | Director | 13,091 | Jun 12, 2024 | 0 |
| Trachtenberg Eric | SEE REMARKS | 68,066 | Jan 5, 2024 | 0 |
| Paull Robert Bradley | Director | – | Jun 17, 2022 | 0 |
| RA Capital Healthcare Fund LP | 10% Owner | 7,039,613Indirect | May 26, 2022 | 0 |
| Ra Capital Management, L.P. | 10% Owner | 7,039,613Indirect | May 26, 2022 | 0 |
| Kolchinsky Peter | 10% Owner | 7,039,613Indirect | May 26, 2022 | 0 |
| Shah Rajeev M. | 10% Owner | 7,039,613Indirect | May 26, 2022 | 0 |
| Chen Hongming | CHIEF SCIENTIFIC OFFICER | 204,515 | Oct 28, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 4, 2025 (view filing) | Jun 3 | 1 day | Brazzell Romulus KSEE REMARKS | SSale | −3.69K | $3.74 | −$13.8K | −4.0%87.9K after | |
| Jun 4, 2025 (view filing) | Jun 3 | 1 day | Bazemore ToddSEE REMARKS | SSale | −3.39K | $3.74 | −$12.7K | −3.7%87.8K after | |
| Jun 4, 2025 (view filing) | Jun 3 | 1 day | Reumuth MaryCHIEF FINANCIAL OFFICER | SSale | −2.85K | $3.74 | −$10.7K | −4.2%65.7K after | |
| Jun 4, 2025 (view filing) | Jun 3 | 1 day | Kharabi DariusCHIEF BUSINESS OFFICER | SSale | −730 | $3.74 | −$2.73K | −1.1%67.1K after | |
| Jun 5, 2025 (view filing) | Jun 3 | 2 days | Iwicki Mark TDirector | SSale | −10.9K | $3.74 | −$40.6K | −3.9%269.2K after | Amended |
| Jun 26, 2025 (view filing) | Jun 24 | 2 days | Iwicki Mark TDirector | SSale | −13.2K | $4.01 | −$53.0K | −4.9%258.4K after | |
| Jun 26, 2025 (view filing) | Jun 24 | 2 days | Brazzell Romulus KSEE REMARKS | SSale | −5.25K | $4.01 | −$21.1K | −6.0%82.7K after | |
| Jun 26, 2025 (view filing) | Jun 24 | 2 days | Bazemore ToddSEE REMARKS | SSale | −4.06K | $4.01 | −$16.3K | −4.6%83.7K after | |
| Jun 26, 2025 (view filing) | Jun 24 | 2 days | Reumuth MaryCHIEF FINANCIAL OFFICER | SSale | −3.63K | $4.01 | −$14.6K | −5.5%62.1K after | |
| Jun 26, 2025 (view filing) | Jun 24 | 2 days | Kharabi DariusCHIEF BUSINESS OFFICER | SSale | −4.51K | $4.01 | −$18.1K | −6.7%62.6K after | |
| Oct 2, 2025 (view filing)4:47 PM ET | Sep 30-Oct 1 | 2 days | Baker Julian and 3 othersOther: Former 10% owner | SSale | −730.4K | $1.45 | −$1.06M | −63.2%425.0K after | 4 lots |
| Oct 24, 2025 (view filing) | Oct 22 | 2 days | Brazzell Romulus KSEE REMARKS | SSale | −46.7K | $0.83 | −$38.8K | −56.5%36.0K after | |
| Oct 24, 2025 (view filing) | Oct 23 | 1 day | Iwicki Mark TDirector | SSale | −154.9K | $0.81 | −$125.5K | −59.9%103.5K after | |
| Oct 24, 2025 (view filing) | Oct 22 | 2 days | Bazemore ToddDirector | SSale | −47.8K | $0.83 | −$39.6K | −57.1%35.9K after | |
| Oct 24, 2025 (view filing) | Oct 22-23 | 2 days | Reumuth MaryCHIEF FINANCIAL OFFICER | SSale | −33.2K | $0.8297 | −$27.5K | −53.5%28.9K after | 2 lots |
| Oct 24, 2025 (view filing) | Oct 22 | 2 days | Kharabi DariusCHIEF BUSINESS OFFICER | SSale | −20.8K | $0.83 | −$17.3K | −33.3%41.8K after |